By Susan Ning, Ziqing Zheng and Rui Li
On August 13, 2013, China’s Ministry of Commerce (MOFCOM) announced on its website that it has conditionally approved the $4 billion acquisition of Swedish medical technology company Gambro AB by Baxter International.
Baxter is a US-based healthcare company, which develops, manufactures and markets products used in the treatment of patients suffering from hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other acute medical conditions.
Continue Reading MOFCOM Conditionally Cleared Baxter’s $4 Billion Acquisition of Gambro




2011年8月,中国证券监督管理委员会(以下简称“证监会”)作出《关于修改上市公司重大资产重组与配套融资相关规定的决定》,对2008年5月开始实施的《上市公司重大资产重组管理办法》以下简称(“《重组管理办法》”)进行修订,开始允许上市公司在发行股份购买资产的同时,募集部分配套资金。